[금일 제약업계 주요기사] Celltrion antibody treatment’approved’… Bukwang Pharmaceutical “Corona 19 treatment, clinical phase 2 IND approval by the US FDA, etc.
Bukwang Pharmaceuticals “Corona 19 treatment acquired IND approval for Phase 2 clinical trial by the US FDA”
“SK-developed corona vaccine, phase 3 clinical trial after securing interim results in the third quarter”
Cellmaterapeutics completes application for approval for Phase 3 clinical trial in France for COVID-19 treatment
Medical News Mobile Site Announces’Selection and Concentration’ to Support 3 Phase Costs for Domestic Corona 19 Vaccine Development